Immediate Impact
21 standout
Citing Papers
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout
Works of May Moonan being referenced
Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis
2011
Impaired circulating glucagon‐like peptide‐1 response to oral glucose in women with previous gestational diabetes
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| May Moonan | 13 | 8 | 26 | 16 | 2 | 67 | |
| Jennifer Goss | 14 | 13 | 25 | 23 | 3 | 173 | |
| P. S. Hench | 8 | 5 | 8 | 22 | 2 | 96 | |
| Linda E Kelemen | 18 | 3 | 28 | 31 | 4 | 183 | |
| Philip Gardiner | 18 | 23 | 29 | 8 | 3 | 201 | |
| Chirag Pasricha | 16 | 15 | 11 | 6 | 7 | 164 | |
| Shan Jiang | 5 | 5 | 28 | 6 | 6 | 174 | |
| M Schvartz | 5 | 4 | 4 | 9 | 4 | 166 | |
| G. Gargiulo | 27 | 7 | 25 | 69 | 4 | 182 | |
| J. OTTESEN | 9 | 13 | 22 | 6 | 3 | 174 | |
| George Alexiadis | 23 | 10 | 28 | 15 | 5 | 69 |
All Works
Loading papers...